Please login to the form below

Not currently logged in
Email:
Password:

GSK commended for community work

GlaxoSmithKline has become one of the first companies to be awarded the new 'CommunityMark' by UK organisation
GlaxoSmithKline (GSK) has become one of the first companies to be awarded the new 'CommunityMark' by UK organisation, Business in the Community (BITC), after being assessed alongside leading retailers, banks and professional service firms.

BITC's CommunityMark is a new initiative that rewards companies for their investment in community and is endorsed by the government and voluntary sector leaders. It recognises firms that have achieved the highest standards in this area and GSK is the only manufacturer that has, to date, received the award.

GSK was given the CommunityMark for its work at local and national level in the UK as well as for its international programmes.

"The rigorous assessment process employed by BITC makes the recognition of our long-term commitment to community investment all the more significant. We are proud to have been awarded the CommunityMark," said Andrew Witty, chief executive of GSK. "The combined efforts of developing innovative medicines and vaccines alongside our work with communities can have a genuine impact on society."

The assessment process for the award saw GSK having to demonstrate to a review panel that it has a long-term, high-level commitment to community investment by using examples such as its positive action programme for HIV/AIDS. The award is applicable for a period of three years, after which GSK can apply for it to be renewed.

In total, 21 UK companies have been granted a CommunityMark by the BITC.

8th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics